Director David Sidransky Files Amended Holdings Report for Ascentage Pharma
ASCENTAGE PHARMA GROUP INTERNATIONAL
Subscribe to track AAPG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Director David Sidransky Files Amended Holdings Report for Ascentage Pharma
Company: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form: 3/A (Amendment) | Filed: 2026-03-23 Significance: Low
Insider: SIDRANSKY DAVID Title: Director | Relationship: Director
Filing Details: • Type: Initial Statement of Beneficial Ownership (Amendment) • Correction: Reporting previously omitted holdings • Direct Holdings: 10,641 Ordinary Shares • Derivatives: 18,850 Options ($8.14 strike) & 28,850 RSUs
Key Insight: This is an administrative correction to the insider's initial ownership report. It does not represent a new open market purchase or sale.
Market Context: Ascentage Pharma is a $16.35B market cap company. These holdings represent ~0.015% of shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Director David Sidransky filed a Form 3/A to correct and report previously omitted holdings of ordinary shares and derivatives.
- Market Impact: Neutral. This is an administrative compliance update, not a transactional signal.
Company Information
| Field | Value |
|---|---|
| Company | ASCENTAGE PHARMA GROUP INTERNATIONAL |
| Ticker Symbol | AAPG |
| CIK | 0002023311 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | SIDRANSKY DAVID |
| CIK | 0001277161 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3/A (Amendment) |
| Report Date | 2026-03-18 |
| Transaction Code | None (Initial Holding Report) |
| Security Type | Ordinary Shares & Derivatives |
| Shares Reported | 10,641 (Direct Common) |
| Price Per Share | N/A (Holdings Report) |
| Total Value | N/A |
| Shares Owned After | 10,641 (excluding derivatives) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Market Cap | $16.35 Billion |
| Shares Outstanding | 373,320,000 |
| Total Holdings Reported | ~58,341 (Common + Options + RSUs) |
| % of Shares Outstanding | ~0.015% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $16.35 billion, the holdings reported (approximate value <$500k based on option strike context) are immaterial to the broader market structure.
- Ownership Concentration: The insider holds a negligible percentage (<0.1%) of the company's total equity.
- Dilution Impact: The reporting of 18,850 options and 28,850 RSUs represents potential dilution of roughly 0.01%, which is statistically insignificant.
- Transaction Significance: This filing is purely administrative to fix errors in the original Form 3 submission regarding share counts and vesting schedules.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Amendments to initial ownership statements (Form 3/A) are procedural. No shares were bought or sold in the open market.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Correction Details: Footnotes indicate that "The number of Ordinary Shares were inadvertently not reported in the original submission" and option vesting details were corrected.
- Derivatives: The filer holds options exercisable at $8.14 (expiring 2035) and RSUs vesting through 2029, aligning long-term incentives.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.